Thrift, A. P., El-Serag, H. B. & Kanwal, F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat. Rev. Gastroenterol. Hepatol. 14, 122–132. https://doi.org/10.1038/nrgastro.2016.176 (2017).
Google Scholar
Adler, M., Goubau, P., Nevens, F. & Van Vlierberghe, H. Hepatitis C virus: The burden of the disease. Acta Gastroenterol. Belg. 65, 83–86 (2002).
Google Scholar
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D. & Wiersma, S. T. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57, 1333–1342. https://doi.org/10.1002/hep.26141 (2013).
Google Scholar
Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. Lancet Gastroenterol. Hepatol 2, 161–176. https://doi.org/10.1016/S2468-1253(16)30181-9 (2017).
Google Scholar
Younossi, Z., Park, H., Henry, L., Adeyemi, A. & Stepanova, M. Extrahepatic manifestations of hepatitis C: A meta-analysis of prevalence, quality of life, and economic burden. Gastroenterology 150, 1599–1608. https://doi.org/10.1053/j.gastro.2016.02.039 (2016).
Google Scholar
Songtanin, B. & Nugent, K. Burden, outcome, and comorbidities of Extrahepatic manifestations in hepatitis C virus infection. Biology 12, 23. https://doi.org/10.3390/biology12010023 (2022).
Google Scholar
Naing, C., Mak, J. W., Ahmed, S. I. & Maung, M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Meta-analysis. World J. Gastroenterol. 18, 1642–1651. https://doi.org/10.3748/wjg.v18.i14.1642 (2012).
Google Scholar
Mason, A. L. et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29, 328–333. https://doi.org/10.1002/hep.510290235 (1999).
Google Scholar
Zheng, Y., Ley, S. H. & Hu, F. B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 14, 88–98. https://doi.org/10.1038/nrendo.2017.151 (2018).
Google Scholar
Babiker, A. et al. Risk of cardiovascular disease due to chronic hepatitis C infection: a review. J. Hepatol. 5, 343–362. https://doi.org/10.1016/j.jhep.2016.07.039 (2017).
Google Scholar
Butt, A. A., Wang, X. & Fried, L. F. HCV infection and the incidence of CKD. Am. J. Kidney Dis. 57, 396–402. https://doi.org/10.1053/j.ajkd.2010.09.023 (2011).
Google Scholar
Hsu, Y. C. et al. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. Hepatology 59, 1293–1302. https://doi.org/10.1002/hep.26892 (2014).
Google Scholar
Fowkes, F. G. et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 382, 1329–1340. https://doi.org/10.1016/S0140-6736(13)61249-0 (2013).
Google Scholar
Gerhard-Herman, M. D. et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation 135, e726–e779. https://doi.org/10.1161/CIR.0000000000000471 (2017).
Google Scholar
Hsu, Y. H. et al. Hepatitis C virus infection increases the risk of developing peripheral arterial disease: A 9-year population-based cohort study. J. Hepatol. 62, 519–525. https://doi.org/10.1016/j.jhep.2014.09.022 (2015).
Google Scholar
Dunkler, D. et al. Risk prediction for early CKD in type 2 diabetes. Clin. J. Am. Soc. Nephrol. 10, 1371–1379. https://doi.org/10.2215/CJN.10321014 (2015).
Google Scholar
Gerstein, H. C. et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286, 421–426. https://doi.org/10.1001/jama.286.4.421 (2001).
Google Scholar
ElSayed, N. A. et al. 11. Chronic kidney disease and risk management: standards of care in diabetes-2023. Diabetes Care 46, S191–S202. https://doi.org/10.2337/dc23-S011 (2023).
Google Scholar
Liangpunsakul, S. & Chalasani, N. Relationship between hepatitis C and microalbuminuria: results from the NHANES III. Kidney Int. 67, 285–290. https://doi.org/10.1111/j.1523-1755.2005.00080.x (2005).
Google Scholar
Tsui, J. I., Vittinghoff, E., Shlipak, M. G. & O’Hare, A. M. Relationship between hepatitis C and chronic kidney disease: Results from the third national health and nutrition examination survey. J. Am. Soc. Nephrol. 17, 1168–1174. https://doi.org/10.1681/ASN.2005091006 (2006).
Google Scholar
Huang, J. F. et al. Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?. Intern. Med. 260, 255–262. https://doi.org/10.1111/j.1365-2796.2006.01686.x (2006).
Google Scholar
Bennett, H. et al. A review of the burden of hepatitis C infection in China, Japan, South Korea and Taiwan. Hepatol. Int. 9, 378–390. https://doi.org/10.1007/s12072-015-9629-x (2015).
Google Scholar
Yu, M. L. et al. Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: A nationwide survey in Taiwan. Medicine 94, e690. https://doi.org/10.1097/MD.0000000000000690 (2015).
Google Scholar
Huang, J. F. et al. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: An epidemiological link with virological implication. Am. J. Gastroenterol. 102, 1237–1243. https://doi.org/10.1111/j.1572-0241.2007.01181.x (2007).
Google Scholar
Taiwan hepatitis C policy guidelines 2018–2025. Taipei City: Ministry of Health and Welfare, Executive Yuan Taiwan. https://www.globalhep.org/evidence-base/taiwan-hepatitis-c-policy-guidelines-2018-2025 (2019).
Kurbanova, N. & Qayyum, R. Association of hepatitis C virus infection with proteinuria and glomerular filtration rate. Clin. Transl. Sci. 8, 421–424. https://doi.org/10.1111/cts.12321 (2015).
Google Scholar
Aytug, S., Reich, D., Sapiro, L. E., Bernstein, D. & Begum, N. Impaired IRS-1/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes. Hepatology 38, 1384–1392. https://doi.org/10.1016/j.hep.2003.09.012 (2003).
Google Scholar
Kawaguchi, T. et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am. J. Pathol. 165, 1499–1508. https://doi.org/10.1016/S0002-9440(10)63408-6 (2004).
Google Scholar
Konrad, T. et al. Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infection. Digestion 62, 52–59. https://doi.org/10.1159/000007778 (2000).
Google Scholar
Narita, R. et al. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J. Hepatol. 41, 132–138. https://doi.org/10.1016/j.jhep.2004.03.020 (2004).
Google Scholar
Shintani, Y. et al. Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterology 126, 840–848. https://doi.org/10.1053/j.gastro.2003.11.056 (2004).
Google Scholar
Sarafidis, P. A. & Ruilope, L. M. Insulin resistance, hyperinsulinemia, and renal injury: Mechanisms and implications. Am. J. Nephrol. 26, 232–244. https://doi.org/10.1159/000093632 (2006).
Google Scholar
Johnson, R. J. et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N. Engl. J. Med. 328, 465–470. https://doi.org/10.1056/NEJM199302183280703 (1993).
Google Scholar
Fabrizi, F. et al. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease. Am. J. Kidney Dis. 61, 623–637. https://doi.org/10.1053/j.ajkd.2012.08.040 (2013).
Google Scholar
Sabry, A. et al. HCV associated glomerulopathy in Egyptian patients: Clinicopathological analysis. Virology 334, 10–16. https://doi.org/10.1016/j.virol.2005.01.013 (2005).
Google Scholar
Habas, E. et al. Hepatitis virus C-associated nephropathy: A review and update. Cureus 14, e27322. https://doi.org/10.7759/cureus.27322 (2022).
Google Scholar
Lai, T. S. et al. High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease. Kidney int. 92, 703–709. https://doi.org/10.1016/j.kint.2017.03.021 (2017).
Google Scholar
Lai, T. S. et al. Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study. Hepatology 66, 784–793. https://doi.org/10.1002/hep.29192 (2017).
Google Scholar
Chen, Y. C., Lin, H. Y., Li, C. Y., Lee, M. S. & Su, Y. C. A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease. Kidney int. 85, 1200–1207. https://doi.org/10.1038/ki.2013.455 (2014).
Google Scholar
Cedarbaum, E. et al. Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women. AIDS 33, 2025–2033. https://doi.org/10.1097/QAD.0000000000002319 (2019).
Google Scholar
Matsumae, T. et al. What factors accelerate aortic stiffening in hemodialysis patients? An observational study. Hypertens. Res. 33, 243–249. https://doi.org/10.1038/hr.2009.219 (2010).
Google Scholar
Sheen, Y. J., Hsu, C. C., Kung, P. T., Chiu, L. T. & Tsai, W. C. Impact of chronic hepatitis on cardiovascular events among type 2 diabetes patients in Taiwan pay-for-performance program. Sci. Rep. 12, 11720. https://doi.org/10.1038/s41598-022-15827-x (2022).
Google Scholar
Dachun, Xu. et al. Sensitivity and specificity of the ankle–brachial index to diagnose peripheral artery disease: A structured review. Vasc. Med. 15, 361–369. https://doi.org/10.1177/1358863X10378376 (2010).
Google Scholar
Wang, A. C., Geng, J. H., Wang, C. W., Wu, D. W. & Chen, S. C. Sex difference in the associations among risk factors with hepatitis B and C infections in a large Taiwanese population study. Front. Public Health 10, 1068078. https://doi.org/10.3389/fpubh.2022.1068078 (2022).
Google Scholar
Lefrère, J. J. et al. Full or partial seroreversion in patients infected by hepatitis C virus. J. Infect. Dis. 175, 316–322. https://doi.org/10.1093/infdis/175.2.316 (1997).
Google Scholar
Chen, C. H. et al. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J. Formos. Med. Assoc. 106, 148–155. https://doi.org/10.1016/S0929-6646(09)60231-X (2007).
Google Scholar
Sun, C. A. et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: The important role of iatrogenic risk factors. J. Med. Virol. 65, 30–34 (2001).
Google Scholar
Akkaya, O., Kiyici, M., Yilmaz, Y., Ulukaya, E. & Yerci, O. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World J. Gastroenterol. 13, 5481–5485. https://doi.org/10.3748/wjg.v13.i41.5481 (2007).
Google Scholar
Gulcan, A., Gulcan, E., Toker, A., Bulut, I. & Akcan, Y. Evaluation of risk factors and seroprevalence of hepatitis B and C in diabetic patients in Kutahya, Turkey. J. Investig. Med. 56, 858–863. https://doi.org/10.2310/JIM.0b013e3181788d28 (2008).
Google Scholar
Korkmaz, H. et al. Assessment of evidence for positive association and seroprevalence of hepatitis B and C in diabetic patients in a developing country. J. Investig. Med. 63, 251–257. https://doi.org/10.1097/JIM.0000000000000126 (2015).
Google Scholar
Puoti, C., Castellacci, R. & Montagnese, F. Hepatitis C virus carriers with persistently normal aminotransferase levels: Healthy people or true patients?. Dig. Liver Dis. 32, 634–643. https://doi.org/10.1016/s1590-8658(00)80850-6 (2000).
Google Scholar
Chen, Y. C., Wang, H. W., Huang, Y. T. & Jiang, M. Y. Association of hepatitis C virus infection status and genotype with kidney disease risk: A population-based cross-sectional study. PLoS One 17, e0271197. https://doi.org/10.1371/journal.pone.0271197 (2022).
Google Scholar
Lee, I. T. et al. Pay-for-performance for shared care of diabetes in Taiwan. J. Formos. Med. Assoc. 118, S122–S129. https://doi.org/10.1016/j.jfma.2019.08.011 (2019).
Google Scholar
Chen, Y. C., Liao, Y. H., Ku, L. E. & Wang, J. D. Pay-for-performance and continuity of care synergistically reduced amputation of lower extremity in patients with diabetes: A population-based cohort study. BMC Health Serv. Res. 22, 748. https://doi.org/10.1186/s12913-022-08075-2 (2022).
Google Scholar
Hsieh, H. M. et al. The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study. Prev. Med. 85, 53–59. https://doi.org/10.1016/j.ypmed.2015.12.013 (2016).
Google Scholar
Diabetes Association of The Republic of China Taiwan. Executive summary of the DAROC clinical practice guidelines for diabetes care- 2018. J. Formos. Med. Assoc. 119, 577–586. https://doi.org/10.1016/j.jfma.2019.02.016 (2020).
Google Scholar
